SCHEMBL484584

SCHEMBL484584

N#Cc1cccc(CN2CCC3(CC2)CCN(C(=O)c2ccc4c(c2)C(NC(=O)c2ccccc2Cl)CC4)C3)c1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP3A4 P08684 6/20 0.43
CYP2D6 P10635 6/20 0.43
USP2 O75604 5/20 0.43
ACKR3 P25106 2/20 0.42
CYP1A2 P05177 4/20 0.42
HPGD P15428 2/20 0.42
ALDH1A1 P00352 3/20 0.41
CHRM2 P08172 2/20 0.41
CHRM3 P20309 2/20 0.41
GLA P06280 1/20 0.41
CYP2C19 P33261 1/20 0.41
TAS1R3 Q7RTX0 1/20 0.41
TAS1R1 Q7RTX1 1/20 0.41
TAS1R2 Q8TE23 1/20 0.41
MAPK1 P28482 2/20 0.40
CYP2C9 P11712 2/20 0.40
TSHR P16473 2/20 0.40
CCR8 P51685 1/20 0.39
KCNH2 Q12809 1/20 0.39
SMN1; SMN2 Q16637 3/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL484474 0.96 CYP2D6 (0.47) CYP3A4CYP2D6USP2ACKR3CYP1A2
SCHEMBL484732 0.94 CYP3A4 (0.48) CYP3A4CYP2D6USP2CYP1A2HPGD
SCHEMBL485200 0.90 USP2 (0.44) CYP3A4CYP2D6USP2ACKR3CYP1A2
SCHEMBL484589 0.90 CYP3A4 (0.45) CYP3A4CYP2D6USP2ACKR3CYP1A2
SCHEMBL484600 0.90 CYP3A4 (0.41) CYP3A4CYP2D6USP2ACKR3CYP1A2
SCHEMBL484809 0.89 USP2 (0.53) CYP3A4CYP2D6USP2CYP1A2ALDH1A1
SCHEMBL484329 0.87 TAS1R3 (0.42) CYP3A4CYP2D6USP2ACKR3ALDH1A1
SCHEMBL484850 0.87 CYP3A4 (0.51) CYP3A4CYP2D6USP2CYP1A2ALDH1A1
SCHEMBL484793 0.86 ACKR3 (0.42) CYP3A4CYP2D6USP2ACKR3CYP1A2
SCHEMBL484736 0.86 USP2 (0.49) CYP3A4CYP2D6USP2CYP1A2ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20130231327-A1 Substituted Spiro-Amide Compounds GRUENENTHAL GMBH (DE) 2013-09-05 US claimed
US-8455475-B2 Substituted spiro-amide compounds GRUENENTHAL GMBH (DE) 2013-06-04 US claimed
EP-2411381-A1 SUBSTITUTED SPIRO-AMIDE COMPOUNDS Grünenthal GmbH (DE) 2012-02-01 EP claimed
US-20100249095-A1 Substituted Spiro-amide Compounds GRUENENTHAL GMBH (DE) 2010-09-30 US claimed
WO-2010108651-A1 SUBSTITUTED SPIRO-AMIDE COMPOUNDS Grünenthal GmbH (DE) 2010-09-30 WO claimed
US-20130231327-A1 Substituted Spiro-Amide Compounds GRUENENTHAL GMBH (DE) 2013-09-05 US disclosed
US-8455475-B2 Substituted spiro-amide compounds GRUENENTHAL GMBH (DE) 2013-06-04 US disclosed
EP-2411381-A1 SUBSTITUTED SPIRO-AMIDE COMPOUNDS Grünenthal GmbH (DE) 2012-02-01 EP disclosed
US-20100249095-A1 Substituted Spiro-amide Compounds GRUENENTHAL GMBH (DE) 2010-09-30 US disclosed
WO-2010108651-A1 SUBSTITUTED SPIRO-AMIDE COMPOUNDS Grünenthal GmbH (DE) 2010-09-30 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20130231327-A1 Substituted Spiro-Amide Compounds BDKRB1, BDKRB2, REN CYP3A4 3781/4885CYP2D6 1926/4885USP2 4864/4885
US-20100249095-A1 Substituted Spiro-amide Compounds BDKRB1, BDKRB2, REN CYP3A4 3781/4885CYP2D6 1926/4885USP2 4864/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.